BlueWillow Biologics
PrivateLast Round
Grant
Sep 1, 2020
Total Funding Raised
$134.18M
Company Overview
BlueWillow Biologics operates in Healthcare & Life Sciences and is based in Ann Arbor, Michigan. Its latest recorded funding round was a Grant round in September 2020.
BlueWillow Biologics is a biotechnology company that develops intranasal vaccines and adjuvant technology to protect against infectious diseases and food allergies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BlueWillow Biologics Comparables
Compare BlueWillow Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Blue Lake Biotechnology, Inc. | 82% | |
| Codagenix | 79% | |
| Altimmune Inc | 77% |
For institutional investors. Book with your work email.
BlueWillow Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2020 | ||||
| Grant | Oct 1, 2019 | ||||
| Grant | May 29, 2019 | ||||
| Series A | May 7, 2018 | ||||
| Grant | Apr 4, 2018 | ||||
Grant | Mar 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BlueWillow Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| North Coast Technology Investors | Series A |
| National Institute of Allergy and Infectious Diseases | Grant |
| Perseus, L.L.C. | Series C, Series B, Private Equity |
| Venture Investors LLC | Series B, Series C |
| Bill & Melinda Gates Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 577% MoM.
- Sep 1, 2020
Raised $8M Grant round
For institutional investors. Book with your work email.
BlueWillow Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BlueWillow Biologics's valuation, stock price, and market status.
Is BlueWillow Biologics a public or private company?
BlueWillow Biologics is a private company.
What is the current stock price of BlueWillow Biologics?
BlueWillow Biologics is a private company, so its shares have no public market price. Caplight tracks BlueWillow Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BlueWillow Biologics worth (valuation)?
Valuation information for BlueWillow Biologics is not publicly available.
Can I buy BlueWillow Biologics stock?
BlueWillow Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BlueWillow Biologics's last funding round?
BlueWillow Biologics's most recent funding round was Grant on September 1, 2020.
Who are the main investors in BlueWillow Biologics?
Key investors in BlueWillow Biologics include North Coast Technology Investors, Perseus, L.L.C..
Will BlueWillow Biologics IPO soon?
No public IPO plans have been announced for BlueWillow Biologics.
How can I track BlueWillow Biologics secondary market activity?
Caplight tracks bids, offers, and trades in BlueWillow Biologics's shares on secondary markets.